Member Info for JSB1989

Lots of possibilities for grants and funding. Legacy sellers must be nearly done. Price moving up on small buys!

Nice tick up too!

All opinions and views welcome as long as they are constructive and researched.

I understand that Cathal doesn’t want to push drug discovery and rather play it safe with pharma services. I do however hope that they are actively talking to other pharmas about deals or partnerships relating to phase 3 trials with Flu-V. It’s potential must be capitalised on in the next few months. We could either sell the rights of the drug to another pharma for multiples of our MC or offer a % of the future revenue for fully funding a phase 3 trial. Personally I prefer the idea of the latter, no financial risk and massive upside.

Stupid cheap at the moment!

There appears to have been some frequent selling in rounded blocks of 100,000 to 150,000 which has caused this to drift. I wonder if this is the legacy sellers finishing off.

We just need some patience here and the news flow will come. The company is incredibly busy right now and will continue to be during the shutdown

Time to load up and take a few more!!

You wouldn’t want to be invested elsewhere at this time. So many developments are about to happen with the company and is very much in demand which = significant revenue and cash flow.

Absolutely not missed the boat. We are highly unlikely to be the company to develop the first coronavirus vaccine. The world will look very different at flu and viruses after this pandemic. It won’t be brushed under the carpet like it was after the SARs and MERs outbreak. Governments now understand the need to develop weapons and further research to combat these in the future. Our Flu-V is one of these potential game changers

10p is very realistic in the short term. Personally I think the potential is far greater. More interest is been generated on a weekly basis and the herd will flock over when they realise money can be made here without the huge risk of market swings

Deal!

deepjoy, I’m not saying this is going to 50bag but the potential is much larger than your view. The world is focusing in this niche area of virology particularly in Flu and Coronavirus for help in both research and development of vaccines and anti viral drugs. Governments are already pledging money for R&D on the virus and any big pharma which have stacks of cash will try to capitalise.

Agreed bunsenburner, my conservative view is 30p on positive news flow and the market will likely over react to any news on flu vaccines and development in research on the coronavirus. NCYT did over 1000% on bloody testing kits!

Had a top up myself this morning. It’s not staying here for long. Plenty of news flow in the coming weeks and shown to be a safe haven in these brutal markets

Wouldn’t want to be anywhere else! Should bounce back over 6p after the initial shock of this morning. Investors will be scanning for any opportunity to make money, its right here!

Of course it will. Gold stocks in this climate are the most resilient. POG is still over $1600 which is profitable for GDP. People are fearing further drops and turning any holdings to cash.

With the funding promised by governments to fight coronavirus by finding a vaccination we are in a prime position to capitalise. News could drop in a few days, weeks or months which will transform the company and share price. £150-£300 million cap seems reasonable in 6-9 months.

Clearly someone dumping shares which is holding us back

Good example bunsenburner. Vaccines for flu/coronavirus are going to be huge business in the next couple of years. Plenty of government grants and funding possible. Multi bag potential in months not years for me